Assura Plc (LON:AGR - Get Free Report) insider Jayne Cottam purchased 369 shares of the business's stock in a transaction that occurred on Thursday, December 5th. The shares were purchased at an average cost of GBX 41 ($0.52) per share, with a total value of £151.29 ($192.80).
Jayne Cottam also recently made the following trade(s):
- On Monday, October 7th, Jayne Cottam purchased 357 shares of Assura stock. The shares were purchased at an average cost of GBX 42 ($0.54) per share, with a total value of £149.94 ($191.08).
Assura Trading Down 0.9 %
Shares of Assura stock traded down GBX 0.38 ($0.00) during trading on Monday, reaching GBX 39.92 ($0.51). 5,289,265 shares of the company were exchanged, compared to its average volume of 9,080,482. Assura Plc has a twelve month low of GBX 37.54 ($0.48) and a twelve month high of GBX 49.18 ($0.63). The business has a 50-day moving average price of GBX 40.17 and a 200-day moving average price of GBX 40.86. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.04. The firm has a market capitalization of £1.30 billion, a price-to-earnings ratio of -3,988.00, a P/E/G ratio of 3.60 and a beta of 0.37.
Assura Announces Dividend
The company also recently announced a dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, December 12th will be paid a GBX 0.84 ($0.01) dividend. This represents a yield of 2.12%. The ex-dividend date is Thursday, December 12th. Assura's payout ratio is presently -30,000.00%.
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on AGR shares. Shore Capital reaffirmed a "hold" rating on shares of Assura in a research note on Tuesday, August 13th. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 51 ($0.65) target price on shares of Assura in a research note on Tuesday, September 17th.
View Our Latest Stock Report on AGR
About Assura
(
Get Free Report)
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.
Featured Stories
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.